Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AudioCodes Ltd.
10.5% sales growth and 7.23% return on equity
AudioCodes Ltd.
AudioCodes Ltd.'s sales growth this year is anticipated to be 9.9% and 10.4% for next year.
Year-on-year quarterly revenue growth grew by 10%, now sitting on 214.9M for the twelve trailing months.
AudioCodes Ltd.'s sales growth for the next quarter is 10.5%. The company's growth estimates for the current quarter and the next is 42.3% and 28%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.23%.
Volatility
AudioCodes Ltd.'s last day, last week, and last month's average volatility was 0.58%, 1.33%, and 0.31%, respectively.
AudioCodes Ltd.'s last day, last week, and last month's high and low average amplitude percentage was 2.17%, 3.29%, and 3.28%, respectively.
AudioCodes Ltd.'s Stock Yearly Top and Bottom Value
AudioCodes Ltd.'s stock is valued at $29.40 at 19:22 EST, way under its 52-week high of $44.94 and way above its 52-week low of $9.00.
AudioCodes Ltd.'s Moving Average
AudioCodes Ltd.'s value is above its 50-day moving average of $27.98 and below its 200-day moving average of $31.47.2. Charles River Laboratories International, Inc.
8.7% sales growth and 17.28% return on equity
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services.
Charles River Laboratories International, Inc.'s sales growth this year is expected to be 10.2% and 10.3% for next year.
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 2.82B for the twelve trailing months.
Charles River Laboratories International, Inc.'s sales growth for the next quarter is 8.7%. The company's growth estimates for the present quarter and the next is 4.5% and 12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.28%.
Volatility
Charles River Laboratories International, Inc.'s last day, last week, and last month's average volatility was 3.30%, 1.15%, and 0.52%, respectively.
Charles River Laboratories International, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.62%, 3.10%, and 2.59%, respectively.
Charles River Laboratories International, Inc.'s Stock Yearly Top and Bottom Value
Charles River Laboratories International, Inc.'s stock is valued at $263.16 at 19:22 EST, below its 52-week high of $263.37 and way above its 52-week low of $95.58.
Charles River Laboratories International, Inc.'s Moving Average
Charles River Laboratories International, Inc.'s value is above its 50-day moving average of $241.37 and way above its 200-day moving average of $220.93.3. HarborOne Bancorp, Inc.
16.7% sales growth and 4.65% return on equity
HarborOne Bancorp, Inc. operates as the holding company for HarborOne Bank that provides financial services to individuals, families, small and middle-market businesses, and municipalities.
HarborOne Bancorp, Inc.'s sales growth this year is expected to be 8.8% and 3.6% for next year.
Year-on-year quarterly revenue growth grew by 40.1%, now sitting on 207.3M for the twelve trailing months.
HarborOne Bancorp, Inc.'s sales growth for the next quarter is 16.7%. The company's growth estimates for the current quarter and the next is 214.3% and 111.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.65%.
Volatility
HarborOne Bancorp, Inc.'s last day, last week, and last month's average volatility was a negative 0.71%, a negative 0.52%, and a positive 0.22%, respectively.
HarborOne Bancorp, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 1.91%, 2.66%, and 2.59%, respectively.
HarborOne Bancorp, Inc.'s Stock Yearly Top and Bottom Value
HarborOne Bancorp, Inc.'s stock is valued at $11.21 at 19:22 EST, under its 52-week high of $11.65 and way above its 52-week low of $6.45.
HarborOne Bancorp, Inc.'s Moving Average
HarborOne Bancorp, Inc.'s value is higher than its 50-day moving average of $10.75 and way higher than its 200-day moving average of $9.30.4. Advanced Energy Industries, Inc.
11% sales growth and 14.52% return on equity
Advanced Energy Industries, Inc. designs, manufactures, sells, and supports precision power conversion, measurement, and control solutions worldwide.
Advanced Energy Industries, Inc.'s sales growth this year is anticipated to be 78.7% and 5.9% for next year.
Year-on-year quarterly revenue growth grew by 122.4%, now sitting on 1.38B for the twelve trailing months.
Advanced Energy Industries, Inc.'s sales growth for the next quarter is 11%. The company's growth estimates for the current quarter and the next is 54% and 26.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.52%.
Volatility
Advanced Energy Industries, Inc.'s last day, last week, and last month's average volatility was 0.65%, 2.99%, and 0.45%, respectively.
Advanced Energy Industries, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 4.04%, 4.92%, and 3.66%, respectively.
Advanced Energy Industries, Inc.'s Stock Yearly Top and Bottom Value
Advanced Energy Industries, Inc.'s stock is valued at $112.26 at 19:22 EST, under its 52-week high of $115.07 and way above its 52-week low of $33.38.
Advanced Energy Industries, Inc.'s Moving Average
Advanced Energy Industries, Inc.'s worth is way higher than its 50-day moving average of $99.47 and way higher than its 200-day moving average of $78.07.5. Zynex, Inc.
86.2% sales growth and 28.99% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
Zynex, Inc.'s sales growth this year is anticipated to be 76.6% and 79.3% for next year.
Year-on-year quarterly revenue growth grew by 69.5%, now sitting on 68.68M for the twelve trailing months.
Zynex, Inc.'s sales growth for the next quarter is 86.2%. The company's growth estimates for the current quarter and the next is a negative 33.3% and negative -22.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.99%.
Volatility
Zynex, Inc.'s last day, last week, and last month's average volatility was a negative 0.12%, a positive 2.67%, and a positive 1.12%, respectively.
Zynex, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 9.66%, 7.98%, and 6.20%, respectively.
Zynex, Inc.'s Stock Yearly Top and Bottom Value
Zynex, Inc.'s stock is valued at $16.52 at 19:22 EST, way under its 52-week high of $29.73 and way higher than its 52-week low of $7.93.